Cargando…

Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis

BACKGROUND: Steroid Responsive Meningitis-Arteritis (SRMA) is a common cause of inflammation of the canine central nervous system (CNS). To investigate if transforming growth factor beta 1 (TGF-β(1)), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) are involved in the production o...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiolini, Arianna, Otten, Meike, Hewicker-Trautwein, Marion, Carlson, Regina, Tipold, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583718/
https://www.ncbi.nlm.nih.gov/pubmed/23379382
http://dx.doi.org/10.1186/1746-6148-9-23
_version_ 1782475472008904704
author Maiolini, Arianna
Otten, Meike
Hewicker-Trautwein, Marion
Carlson, Regina
Tipold, Andrea
author_facet Maiolini, Arianna
Otten, Meike
Hewicker-Trautwein, Marion
Carlson, Regina
Tipold, Andrea
author_sort Maiolini, Arianna
collection PubMed
description BACKGROUND: Steroid Responsive Meningitis-Arteritis (SRMA) is a common cause of inflammation of the canine central nervous system (CNS). To investigate if transforming growth factor beta 1 (TGF-β(1)), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) are involved in the production of excessive immunoglobulin A (IgA), the induction of acute phase proteins and in the development of a systemic necrotizing vasculitis, characteristic of SRMA, these three signalling proteins were evaluated. RESULTS: Cerebrospinal fluid (CSF) and serum samples of dogs during the acute phase of SRMA (SRMA) were tested for IL-6, VEGF and TGF- β(1). Results were compared to those of dogs affected with SRMA during treatment (SRMA Th) and during relapse (SRMA R), to dogs with other meningoencephalomyelitides (ME), with miscellaneous non-inflammatory diseases of the CNS (CNS-Mix), with idiopathic epilepsy (IE), with systemic inflammatory diseases (Syst. Infl.) and with healthy dogs (Healthy). Concentrations of IL-6 and VEGF in CSF were significantly elevated in the SRMA group compared to the other disease categories (p < 0.05). The CSF concentrations of TGF-β(1) were increased in SRMA group, but statistically significant differences were found only in comparison with Healthy and CNS-Mix groups. No differences were detected in the serum concentrations of TGF-β(1) between the different groups. In untreated SRMA patients, a positive correlation (r(Spear) = 0.3549; P = 0.0337) between concentrations of TGF-β(1) and IgA concentration was found in CSF, while concentrations of IL-6 and VEGF in CSF positively correlated with the degree of pleocytosis (r(Spear) = 0.8323; P < 0.0001 and r(Spear) = 0.5711; P = 0.0166, respectively). CONCLUSIONS: Our results suggest that these three signalling proteins are biomarkers of disease activity in SRMA. VEGF might play an important role in the development of a systemic arteritis. TGF-β(1) is considered to be involved in the excessive IgA production, while IL-6 in the pleocytosis. The combined intrathecal increase of TGF-β(1) and IL-6 detected in SRMA could possibly force CD4 progenitors to differentiate towards the newly described Th17 lymphocyte subset and enhance the autoimmune response.
format Online
Article
Text
id pubmed-3583718
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35837182013-02-28 Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis Maiolini, Arianna Otten, Meike Hewicker-Trautwein, Marion Carlson, Regina Tipold, Andrea BMC Vet Res Research Article BACKGROUND: Steroid Responsive Meningitis-Arteritis (SRMA) is a common cause of inflammation of the canine central nervous system (CNS). To investigate if transforming growth factor beta 1 (TGF-β(1)), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) are involved in the production of excessive immunoglobulin A (IgA), the induction of acute phase proteins and in the development of a systemic necrotizing vasculitis, characteristic of SRMA, these three signalling proteins were evaluated. RESULTS: Cerebrospinal fluid (CSF) and serum samples of dogs during the acute phase of SRMA (SRMA) were tested for IL-6, VEGF and TGF- β(1). Results were compared to those of dogs affected with SRMA during treatment (SRMA Th) and during relapse (SRMA R), to dogs with other meningoencephalomyelitides (ME), with miscellaneous non-inflammatory diseases of the CNS (CNS-Mix), with idiopathic epilepsy (IE), with systemic inflammatory diseases (Syst. Infl.) and with healthy dogs (Healthy). Concentrations of IL-6 and VEGF in CSF were significantly elevated in the SRMA group compared to the other disease categories (p < 0.05). The CSF concentrations of TGF-β(1) were increased in SRMA group, but statistically significant differences were found only in comparison with Healthy and CNS-Mix groups. No differences were detected in the serum concentrations of TGF-β(1) between the different groups. In untreated SRMA patients, a positive correlation (r(Spear) = 0.3549; P = 0.0337) between concentrations of TGF-β(1) and IgA concentration was found in CSF, while concentrations of IL-6 and VEGF in CSF positively correlated with the degree of pleocytosis (r(Spear) = 0.8323; P < 0.0001 and r(Spear) = 0.5711; P = 0.0166, respectively). CONCLUSIONS: Our results suggest that these three signalling proteins are biomarkers of disease activity in SRMA. VEGF might play an important role in the development of a systemic arteritis. TGF-β(1) is considered to be involved in the excessive IgA production, while IL-6 in the pleocytosis. The combined intrathecal increase of TGF-β(1) and IL-6 detected in SRMA could possibly force CD4 progenitors to differentiate towards the newly described Th17 lymphocyte subset and enhance the autoimmune response. BioMed Central 2013-02-04 /pmc/articles/PMC3583718/ /pubmed/23379382 http://dx.doi.org/10.1186/1746-6148-9-23 Text en Copyright ©2013 Maiolini et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Maiolini, Arianna
Otten, Meike
Hewicker-Trautwein, Marion
Carlson, Regina
Tipold, Andrea
Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title_full Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title_fullStr Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title_full_unstemmed Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title_short Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
title_sort interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583718/
https://www.ncbi.nlm.nih.gov/pubmed/23379382
http://dx.doi.org/10.1186/1746-6148-9-23
work_keys_str_mv AT maioliniarianna interleukin6vascularendothelialgrowthfactorandtransforminggrowthfactorbeta1incaninesteroidresponsivemeningitisarteritis
AT ottenmeike interleukin6vascularendothelialgrowthfactorandtransforminggrowthfactorbeta1incaninesteroidresponsivemeningitisarteritis
AT hewickertrautweinmarion interleukin6vascularendothelialgrowthfactorandtransforminggrowthfactorbeta1incaninesteroidresponsivemeningitisarteritis
AT carlsonregina interleukin6vascularendothelialgrowthfactorandtransforminggrowthfactorbeta1incaninesteroidresponsivemeningitisarteritis
AT tipoldandrea interleukin6vascularendothelialgrowthfactorandtransforminggrowthfactorbeta1incaninesteroidresponsivemeningitisarteritis